CFRX
:NASDAQ

Add to watchlist
$2.52
Last updated:01/14/2022
CFRX: NASDAQ
$2.52
ContraFect Corporation

ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an investigational novel lysin, which is in Phase III clinical trials for the treatment of staphylococc…

Dividend yield
-
P/E ratio
-
vs. 0.00x forward
Payout ratio
-
Yearly
CASH payout ratio
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
CFRX dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company value
Market capitalization
Micro (99.12M)